Qsemble Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123K Buy
+14,447
New +$96.1K 0.02% 371
2025
Q4
Sell
-193,709
Closed -$1.5M 616
2025
Q3
$1.5M Buy
193,709
+92,683
+92% +$723K 0.15% 202
2025
Q2
$880K Buy
101,026
+56,874
+129% +$412K 0.08% 269
2025
Q1
$351K Buy
+44,152
New +$447K 0.04% 345
2024
Q2
Sell
-61,108
Closed -$923K 573
2024
Q1
$923K Buy
61,108
+51,311
+524% +$931K 0.2% 186
2023
Q4
$211K Buy
+9,797
New +$181K 0.05% 327

Other funds holding TDOC

Qsemble Capital Management's TDOC Position: Q2 2026 in Review

Qsemble Capital Management opened a new position in Teladoc Health (TDOC) in Q2 2026: 14,447 shares worth $123K. The stake represents 0.02% of the portfolio and ranks #371 among its holdings. This is a return to the name: Qsemble Capital Management previously reported a position in TDOC as recently as Q3 2025.

Qsemble Capital Management first reported a position in TDOC in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.5M in Q3 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Qsemble Capital Management held 14,447 shares of Teladoc Health worth $123K as of Q2 2026.
  • Teladoc Health was a new Qsemble Capital Management position in Q2 2026.
  • Teladoc Health made up 0.02% of Qsemble Capital Management's portfolio in Q2 2026, its #371 holding.
  • Qsemble Capital Management first reported a position in Teladoc Health in Q4 2023 and has held it in 6 quarters since.
  • Qsemble Capital Management's Teladoc Health position peaked at $1.5M in Q3 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.